Literature DB >> 20573558

Depressive behaviour in children diagnosed with a mitochondrial disorder.

E Morava1, T Gardeitchik, T Kozicz, L de Boer, S Koene, M C de Vries, R McFarland, T Roobol, R J T Rodenburg, C M Verhaak.   

Abstract

A higher incidence of depression has been described in adults with primary oxidative phosphorylation disease. We evaluated the psychological characteristics of eighteen non-retarded pediatric patients diagnosed with a disorder of the oxidative phosphorylation. We found significantly higher rate of withdrawn, depressive behaviour compared to population norm scores, to children with other types of inborn errors of metabolism and also in comparison to patients with Sotos syndrome. The occurrence of depressive behaviour showed no correlation with the degree of mitochondrial dysfunction. These findings support the hypothesis that mood disorders could be associated to abnormal cerebral energy metabolism. (c) 2010 Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20573558     DOI: 10.1016/j.mito.2010.05.011

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  24 in total

Review 1.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

Review 2.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

3.  Mitochondrial function in the brain links anxiety with social subordination.

Authors:  Fiona Hollis; Michael A van der Kooij; Olivia Zanoletti; Laura Lozano; Carles Cantó; Carmen Sandi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

4.  Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.

Authors:  Wei-hua Shao; Jian-jun Chen; Song-hua Fan; Yang Lei; Hong-bo Xu; Jian Zhou; Peng-fei Cheng; Yong-tao Yang; Cheng-long Rao; Bo Wu; Hai-peng Liu; Peng Xie
Journal:  OMICS       Date:  2015-07

5.  Altitude is a risk factor for completed suicide in bipolar disorder.

Authors:  Rebekah S Huber; Hilary Coon; Namkug Kim; Perry F Renshaw; Douglas G Kondo
Journal:  Med Hypotheses       Date:  2014-01-20       Impact factor: 1.538

6.  Socio-emotional Problems in Children with CDG.

Authors:  K F E van de Loo; L van Dongen; M Mohamed; T Gardeitchik; T W Kouwenberg; S B Wortmann; R J T Rodenburg; D J Lefeber; E Morava; C M Verhaak
Journal:  JIMD Rep       Date:  2013-06-04

Review 7.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

8.  Causes of Death in Adults with Mitochondrial Disease.

Authors:  Marlieke Barends; Lotte Verschuren; Eva Morava; Victoria Nesbitt; Doug Turnbull; Robert McFarland
Journal:  JIMD Rep       Date:  2015-09-10

9.  Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression.

Authors:  Samira Achouitar; Miski Mohamed; Thatjana Gardeitchik; Saskia B Wortmann; Jolanta Sykut-Cegielska; Regina Ensenauer; Hélène Ogier de Baulny; Katrin Õunap; Diego Martinelli; Maaike de Vries; Robert McFarland; Dorus Kouwenberg; Miranda Theodore; Frits Wijburg; Stephanie Grünewald; Jaak Jaeken; Ron A Wevers; Leo Nijtmans; Joanna Elson; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

10.  Early-adolescent antibiotic exposure results in mitochondrial and behavioral deficits in adult male mice.

Authors:  Anouk C Tengeler; Tim L Emmerzaal; Bram Geenen; Vivienne Verweij; Miranda van Bodegom; Eva Morava; Amanda J Kiliaan; Tamas Kozicz
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.